The Medical and Nonoperative Treatment of Diverticulitis

Heath Beckham; Charles B Whitlow

doi:10.1055/s-0029-1236159

Clinics in Colon and Rectal Surgery, Inhaltsverzeichnis

Clin Colon Rectal Surg 2009; 22(3): 156-160
DOI: 10.1055/s-0029-1236159

The Medical and Nonoperative Treatment of Diverticulitis

Heath Beckham¹ , Charles B. Whitlow¹

¹Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, Louisiana

Abstract

ABSTRACT

The success of medical management for diverticular disease depends on the patient's presentation and degree of response to treatment. The patient's presentation can be grouped into categories using classification systems such as the modified Hinchey system. Clinical presentation and diagnostic studies help to group patients. Mild disease can often be managed with oral antibiotics as an outpatient; more severe disease requires hospitalization, bowel rest, and intravenous antibiotics. Interventions such as percutaneous drainage of associated abscesses may allow successful medical management. Probiotics and antiinflammatories may have a supportive role. Indications for elective resections are discussed.

KEYWORDS

Diverticular disease - medical management - antibiotics - percutaneous drainage

Volltext

Referenzen

REFERENCES

1 Jacobs D O. Clinical practice. Diverticulitis. N Engl J Med. 2007; 357(20) 2057-2066
2 Kircher M, Rhea J, Kihiczak D, Novelline R. Frequency, sensitivity, and specificity of individual signs of diverticulitis on thin-section helical CT with colonic contrast material. Am J Roentgenol. 2002; 178 1313-1318
3 Rafferty J, Shellito P, Hyman N H, Buie W D. Standards Committee of American Society of Colon and Rectal Surgeons . Practice parameters for sigmoid diverticulitis. Dis Colon Rectum. 2006; 49(7) 939-944
4 Hinchey E J, Schaal P G, Richards G K. Treatment of perforated diverticular disease of the colon. Adv Surg. 1978; 12 85-109
5 Kaiser A M, Jiang J-K, Lake J P et al.. The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol. 2005; 100(4) 910-917
6 Mizuki A, Nagata H, Tatemichi M et al.. The out-patient management of patients with acute mild-to-moderate colonic diverticulitis. Aliment Pharmacol Ther. 2005; 21(7) 889-897
7 Hjern F, Josephson T, Altman D et al.. Conservative treatment of acute colonic diverticulitis: are antibiotics always mandatory?. Scand J Gastroenterol. 2007; 42(1) 41-47
8 Rao P, Rhea J, Novelline R et al.. Helical CT with only colonic contrast material for diagnosing diverticulitis: prospective evaluation of 150 patients. Am J Roentgenol. 1998; 170 1445-1449
9 Werner A, Diehl S J, Farag-Soliman M, Düber C. Multi-slice spiral CT in routine diagnosis of suspected acute left-sided colonic diverticulitis: a prospective study of 120 patients. Eur Radiol. 2003; 13(12) 2596-2603
10 Ambrosetti P, Becker C, Terrier F. Colonic diverticulitis: impact of imaging on surgical management–a prospective study of 542 patients. Eur Radiol. 2002; 12(5) 1114-1119
11 Ambrosetti P, Chautems R, Soravia C, Peiris-Waser N, Terrier F. Long-term outcome of mesocolic and pelvic diverticular abscesses of the left colon: a prospective study of 73 cases. Dis Colon Rectum. 2005; 48(4) 787-791
12 Siewart B, Tye G, Kruskal J, Sosna J, Opelka F. Impact of CT-guided drainage in the treatment of diverticular abscesses: size matters. Am J Roentgenol. 2006; 186 680-686
13 Small A J, Young-Fadok T M, Baron T H. Expandable metal stent placement for benign colorectal obstruction: outcomes for 23 cases. Surg Endosc. 2008; 22(2) 454-462
14 Forshaw M J, Sankararajah D, Stewart M, Parker M C. Self-expanding metallic stents in the treatment of benign colorectal disease: indications and outcomes. Colorectal Dis. 2006; 8(2) 102-111
15 Paúl L, Pinto I, Gómez H, Fernández-Lobato R, Moyano E. Metallic stents in the treatment of benign diseases of the colon: preliminary experience in 10 cases. Radiology. 2002; 223(3) 715-722
16 Dobbins C, Defontgalland D, Duthie G, Wattchow D A. The relationship of obesity to the complications of diverticular disease. Colorectal Dis. 2006; 8(1) 37-40
17 Stollman N H, Raskin J B. Diverticular disease of the colon. J Clin Gastroenterol. 1999; 29(3) 241-252
18 Painter N S, Burkitt D P. Diverticular disease of the colon: a deficiency disease of Western civilization. BM J. 1971; 2(5759) 450-454
19 Brodribb A J, Humphreys D M. Diverticular disease: three studies. Part II: Treatment with bran. BMJ. 1976; 1(6007) 425-428
20 Hyland J M, Taylor I. Does a high fibre diet prevent the complications of diverticular disease?. Br J Surg. 1980; 67(2) 77-79
21 Taylor I, Duthie H L. Bran tablets and diverticular disease. BMJ. 1976; 1(6016) 988-990
22 Brodribb A J. Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet. 1977; 1(8013) 664-666
23 Smits B J, Whitehead A M, Prescott P. Lactulose in the treatment of symptomatic diverticular disease: a comparative study with high-fibre diet. Br J Clin Pract. 1990; 44(8) 314-318
24 Hodgson W J. The placebo effect. Is it important in diverticular disease?. Am J Gastroenterol. 1977; 67(2) 157-162
25 Ornstein M H, Littlewood E R, Baird I M, Fowler J, North W R, Cox A G. Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial. Br Med J (Clin Res Ed). 1981; 282(6273) 1353-1356
26 Strate L L, Liu Y L, Syngal S, Aldoori W H, Giovannucci E L. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA. 2008; 300(8) 907-914
27 White J A. Probiotics and their use in diverticulitis. J Clin Gastroenterol. 2006; 40(Suppl 3) S160-S162
28 Frič P, Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol. 2003; 15(3) 313-315
29 Tursi A, Brandimarte G, Elisei W et al.. Mesalamine and/or Lactobacillus casei for maintaining remission of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized study. Dig Liver Dis. 2005; 37 S20
30 Papi C, Ciaco A, Koch M, Capurso L. Diverticular Disease Study Group . Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Ital J Gastroenterol. 1992; 24(8) 452-456
31 Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther. 1995; 9(1) 33-39
32 Latella G, Pimpo M T, Sottili S et al.. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis. 2003; 18(1) 55-62
33 D'Incà R, Pomerri F, Vettorato M G et al.. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Aliment Pharmacol Ther. 2007; 25(7) 771-779
34 Colecchia A, Vestito A, Pasqui F et al.. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol. 2007; 13(2) 264-269
35 Di Mario F, Aragona G, Leandro G et al.. Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci. 2005; 50(3) 581-586
36 Comparato G, Fanigliulo L, Aragona G et al.. Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment?. Dig Dis. 2007; 25 252-259
37 Tursi A, Brandimarte G, Giorgetti G M, Elisei W. Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon. Dig Dis Sci. 2007; 52(3) 671-674
38 Tursi A, Brandimarte G, Daffinà R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis. 2002; 34(7) 510-515
39 Brandimarte G, Tursi A. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease. Med Sci Monit. 2004; 10(5) PI70-PI73
40 Salem L, Veenstra D L, Sullivan S D, Flum D R. The timing of elective colectomy in diverticulitis: a decision analysis. J Am Coll Surg. 2004; 199(6) 904-912
41 Richards R J, Hammitt J K. Timing of prophylactic surgery in prevention of diverticulitis recurrence: a cost-effectiveness analysis. Dig Dis Sci. 2002; 47(9) 1903-1908
42 Chapman J, Davies M, Wolff B et al.. Complicated diverticulitis: is it time to rethink the rules?. Ann Surg. 2005; 242(4) 576-581 discussion 581-583
43 Chapman J R, Dozois E J, Wolff B G, Gullerud R E, Larson D R. Diverticulitis: a progressive disease? Do multiple recurrences predict less favorable outcomes?. Ann Surg. 2006; 243(6) 876-830 discussion 880-883
44 Kaiser A M. Complicated diverticulitis: it is not yet time to rethink the rules!. Ann Surg. 2006; 243(5) 707-708, author reply 708–709
45 Novitsky Y, Sechrist C, Payton B, Kercher K, Heniford B. Do the risks of emergent colectomy justify nonoperative management strategies for recurrent diverticulitis?. Am J Surg. 2009; 187(2) 227-231

Charles B WhitlowM.D.

Department of Colon and Rectal Surgery, Ochsner Clinic Foundation

1514 Jefferson Hwy., New Orleans, LA 70121

eMail: cwhitlow@ochsner.org